Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin [Phase 1]
Phase 1 study evaluating potential drug-drug interactions between TNP-2198 and the combination of midazolam and clarithromycin in Helicobact…
-
FDA approval · 2024-10-23FDA Approved: ESOMEPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Esomeprazole under an Original Application for Macleods' generic product, enabling generic market access.
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Knowledge, and Practice of Helicobacter Pylori Infection
Study protocol update from Sohag University focused on knowledge and practice related to Helicobacter pylori infection; recruitment status i…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: European Registry on the Management of Helicobacter Pylori Infection
A European registry study on the management of Helicobacter pylori infection is currently recruiting participants.
-
FDA approval · 2024-09-19FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination drug Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori. [Phase 4]
Phase 4 clinical trial assessing a quadruple therapy of berberine, minocycline, esomeprazole, and colloidal bismuth for initial Helicobacter…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection [Phase 2, Phase 3]
This clinical trial update describes a phase 2/3 study evaluating a quadruple therapy that includes sodium bicarbonate as the primary treatm…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid Arthritis
A clinical trial examining the relationship between Helicobacter pylori infection and disease activity in systemic lupus erythematosus and r…
-
FDA label_change · 2024-09-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lansoprazole from Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the prod…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Argentinean Registry on the Management of Helicobacter Pylori Infection
This ClinicalTrials.gov registry entry describes the Argentinean Registry on the Management of Helicobacter pylori Infection, sponsored by t…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Registration update for a prospective registry and study on Helicobacter pylori infection, atrophic gastritis, and intestinal metaplasia, cu…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Vonoprazan for Helicobacter Pylori Eradication in Adolescents [Phase 3]
A Phase 3 trial evaluating vonoprazan for Helicobacter pylori eradication in adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Helicobacter Pylori and Vonoprazan Dual Therapy [Phase 4]
Phase 4 clinical trial evaluating dual therapy for Helicobacter pylori infection using vonoprazan has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Helicobacter Pylori Prevalence in Southern Region of Romania
Completed clinical trial evaluating the prevalence of Helicobacter pylori infection in the southern region of Romania.
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication [Phase 4]
A Phase 4 clinical trial comparing vonoprazan-based non-bismuth triple therapy (standard or short course) or high-dose dual therapy against …
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection [Phase 1, Phase 2]
A clinical study is evaluating the possible efficacy and safety of a Diosmin and Hesperidin combined therapy for Helicobacter pylori infecti…
-
FDA approval · 2024-07-31FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Triple Pak (vonoprazan fumarate, amoxicillin and clarithromycin) from Phathom Pharm…
-
FDA approval · 2024-07-31FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan fumarate and amoxicillin, to treat Helicobacter p…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy
This clinical trial update reports on treatment adherence and factors influencing adherence in children undergoing eradication therapy for H…
-
FDA approval · 2024-07-17FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for esomeprazole magnesium by Somerset Therapeutics, LLC.
-
FDA approval · 2024-07-17FDA Approved: VOQUEZNA — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for VOQUEZNA (vonoprazan fumarate) filed by Phathom Pharmaceuticals. The action updates the prod…
-
FDA approval · 2024-07-08FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the antibiotic combination Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochl…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating autologous fecal microbiota transplant after Helicobacter pylori antibiotic therapy is currently…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Patient-Centered Cancer Prevention In Chinese Americans [NA]
Completed clinical trial evaluating patient-centered cancer prevention strategies in Chinese Americans with Helicobacter pylori infection. R…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Related Factors of Hp Infection in Physical Examination and Community Population in Hunan Province
The clinical trial investigating factors related to Helicobacter pylori infection in health examinations and community populations in Hunan …